Digestive & Intestinal Remedies (Pharmacies) - Poland

  • Poland
  • Revenue in the Digestives & Intestinal Remedies market is projected to reach €0.43bn in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 6.17%, resulting in a market volume of €0.58bn by 2029.
  • In global comparison, most revenue will be generated in China (€3,090.00m in 2024).
  • In relation to total population figures, per person revenues of €10.63 are generated in 2024.

Key regions: Australia, United States, India, Europe, China

 
Mercado
 
Región
 
Comparación de regiones
 
Moneda
 

Analyst Opinion

The Digestive & Intestinal Remedies (Pharmacies) market in Poland is experiencing significant growth and development.

Customer preferences:
Customers in Poland are increasingly seeking digestive and intestinal remedies from pharmacies due to the convenience and accessibility they offer. Pharmacies provide a wide range of over-the-counter products that cater to various digestive issues, such as indigestion, heartburn, and constipation. Additionally, customers value the professional advice and guidance provided by pharmacists, who can recommend suitable remedies based on individual needs and symptoms.

Trends in the market:
One of the key trends in the Digestive & Intestinal Remedies market in Poland is the growing demand for natural and herbal remedies. Customers are becoming more health-conscious and are actively seeking products that are perceived as safer and more gentle on the body. This trend is driving the development of a wide range of natural and herbal digestive remedies in the market. Furthermore, there is an increasing focus on probiotics and their potential benefits for digestive health. Probiotic supplements and yogurts are gaining popularity among customers looking to improve their gut health.

Local special circumstances:
Poland has a strong tradition of using natural remedies for various ailments, including digestive issues. This cultural preference for natural remedies has influenced the market, with a wide range of traditional Polish herbal remedies available in pharmacies. These remedies often incorporate local herbs and ingredients that are believed to have digestive benefits. The availability of such traditional remedies appeals to customers who value traditional and holistic approaches to healthcare.

Underlying macroeconomic factors:
The growth of the Digestive & Intestinal Remedies market in Poland can be attributed to several macroeconomic factors. Firstly, there is an increasing awareness and understanding of digestive health among the population. This is driven by factors such as changing dietary habits, sedentary lifestyles, and increased stress levels. As a result, more people are seeking remedies to address digestive issues, leading to the growth of the market. Secondly, the rising disposable income in Poland is enabling consumers to spend more on healthcare products, including digestive remedies. As people become more affluent, they are willing to invest in products that can improve their overall health and well-being. This trend is driving the demand for premium and specialized digestive remedies in the market. Lastly, the aging population in Poland is also contributing to the growth of the market. As people age, they are more prone to digestive issues and are more likely to seek remedies to manage these conditions. The increasing elderly population in Poland is creating a larger customer base for digestive remedies, leading to market growth. In conclusion, the Digestive & Intestinal Remedies (Pharmacies) market in Poland is experiencing growth and development due to customer preferences for convenient and accessible remedies, the trend towards natural and herbal products, the cultural preference for traditional remedies, and underlying macroeconomic factors such as increasing awareness of digestive health, rising disposable income, and an aging population.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Visión general

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Espere, por favor

Contacto

¿Alguna duda? Estaremos encantados de atenderte.
Statista Locations
Contacto Nerea Marcos
Nerea Marcos
Client Success Manager

Lu - vi, 9:30 - 17:00 h (CET)

Contacto Meredith Alda
Meredith Alda
Sales Manager– Contacto (Estados Unidos)

Lu - vi, 9:00 - 18:00 h (EST)

Contacto Yolanda Mega
Yolanda Mega
Operations Manager– Contacto (Asia)

Lu - vi, 9:00 - 17:00 h (SGT)

Contacto Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contacto (Asia)

Lu - vi, 10:00 - 18:00 h (JST)

Contacto Lodovica Biagi
Lodovica Biagi
Director of Operations– Contacto (Europa)

Lu - vi, 9:30 - 17:00 h (GMT)

Contacto Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contacto (América Latina)

Lu - vi, 9:00am-6:00pm (EST)